Rtw Investments, LP Akero Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 6,859,823 shares of AKRO stock, worth $310 Million. This represents 3.11% of its overall portfolio holdings.
Number of Shares
6,859,823
Previous 5,919,435
15.89%
Holding current value
$310 Million
Previous $170 Million
12.37%
% of portfolio
3.11%
Previous 2.71%
Shares
4 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$333 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$272 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$252 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$236 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$195 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...